Genetic and biological drivers of prostate cancer disparities in Black men
J Gong, DM Kim, MR Freeman, H Kim, L Ellis… - Nature Reviews …, 2024 - nature.com
Black men with prostate cancer have historically had worse outcomes than white men with
prostate cancer. The causes of this disparity in outcomes are multi-factorial, but a potential …
prostate cancer. The causes of this disparity in outcomes are multi-factorial, but a potential …
Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
AY Deneka, MC Kopp, AS Nikonova, AV Gaponova… - Cancer research, 2021 - AACR
Non–small cell lung cancer (NSCLC) is the most common cancer worldwide. With overall 5-
year survival estimated at< 17%, it is critical to identify factors that regulate NSCLC disease …
year survival estimated at< 17%, it is critical to identify factors that regulate NSCLC disease …
Population-Specific gene expression profiles in prostate cancer: insights from Weighted Gene Co-expression Network Analysis (WGCNA)
This study investigates the genetic factors contributing to the disparity in prostate cancer
incidence and progression among African American men (AAM) compared to European …
incidence and progression among African American men (AAM) compared to European …
How cancer risk SNPs may contribute to prostate cancer disparities
MY Mavura, FW Huang - Cancer Research, 2021 - AACR
Disparities in cancer incidence, prevalence, burden, and outcome exist among specific
population groups in the United States. Researchers have identified germline genetic risk …
population groups in the United States. Researchers have identified germline genetic risk …
[PDF][PDF] Identification of novel tumor antigens and immune subtypes in breast cancer patients for mRNA vaccine development
H Yu, J Liu, L Li, J He, D Li, X Hou, W Cai, Y Chen… - 2024 - scholar.archive.org
Background: Breast cancer has overtaken lung cancer as the world's most common
malignancy. Despite the development of some mRNA vaccines, no satisfactory vaccination …
malignancy. Despite the development of some mRNA vaccines, no satisfactory vaccination …